Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
BridgeBio Pharma, Inc.
BBIO
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | BridgeBio Pharma, Inc. (BBIO) |
|---|---|---|
| Current Price | $19.36 | $46.84 |
| Change | -0.68 (-3.39%) | 0.10 (0.22%) |
| Market Cap | $2.43B | $8.89B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -23.05 | -15.31 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $42.47 | $48.68 |
| 52-Week Low | $16.10 | $21.72 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.80 | $-3.56 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | 9.44% | -35.75% | -49.03% | -42.48% | 37.99% | 37.99% |
| BBIO | 12.26% | 29.84% | 78.87% | 47.64% | 70.04% | 70.04% |